{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:52:47Z","timestamp":1773762767882,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00467-013-2567-8","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T06:33:11Z","timestamp":1377757991000},"page":"1159-1167","source":"Crossref","is-referenced-by-count":35,"title":["The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications"],"prefix":"10.1007","volume":"29","author":[{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandra","family":"Tkachenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Shchekochikhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"2567_CR1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9343(52)90020-X","volume":"13","author":"AA Epstein","year":"1952","unstructured":"Epstein AA (1952) Concerning the causation of edema in chronic parenchymatous nephritis; method for its alleviation. Am J Med 13:556\u2013561","journal-title":"Am J Med"},{"key":"2567_CR2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-91-5-688","volume":"91","author":"JI Meltzer","year":"1979","unstructured":"Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S (1979) Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med 91:688\u2013696","journal-title":"Ann Intern Med"},{"key":"2567_CR3","first-page":"1997","volume-title":"Diseases of the kidney","author":"JKJ Deegens","year":"2012","unstructured":"Deegens JKJ, Schrier RW, Wetzels JFM (2012) The nephrotic syndrome. In: Schrier RW (ed) Diseases of the kidney, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1997\u20132011","edition":"9"},{"key":"2567_CR4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/oxfordjournals.ndt.a027137","volume":"11","author":"JG Walle Van de","year":"1996","unstructured":"Van de Walle JG, Donckerwolcke RA, Greidanus TB, Joles JA, Koomans HA (1996) Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant 11:2202\u20132208","journal-title":"Nephrol Dial Transplant"},{"key":"2567_CR5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archpedi.1967.02090180112010","volume":"113","author":"WJ Oliver","year":"1967","unstructured":"Oliver WJ, Owings CL (1967) Sodium excretion in the nephrotic syndrome. Relation to serum albumin concentration, glomerular filtration rate, and aldosterone excretion rate. Am J Dis Child 113:352\u2013362","journal-title":"Am J Dis Child"},{"key":"2567_CR6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198810203191606","volume":"319","author":"RW Schrier","year":"1988","unstructured":"Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 319:1065\u20131072","journal-title":"N Engl J Med"},{"key":"2567_CR7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/cs0710403","volume":"71","author":"JP O\u2019Hare","year":"1986","unstructured":"O\u2019Hare JP, Roland JM, Walters G, Corrall RJ (1986) Impaired sodium excretion in response to volume expansion induced by water immersion in insulin-dependent diabetes mellitus. Clin Sci (Lond) 71:403\u2013409","journal-title":"Clin Sci (Lond)"},{"key":"2567_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3317\/jraas.2000.065","volume":"1","author":"M Bojestig","year":"2000","unstructured":"Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE (2000) The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes. J Renin-Angiotensin-Aldosterone Syst 1:353\u2013356","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"2567_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.1984.34","volume":"25","author":"M Usberti","year":"1984","unstructured":"Usberti M, Federico S, Meccariello S, Cianciaruso B, Balletta M, Pecoraro C, Sacca L, Ungaro B, Pisanti N, Andreucci VE (1984) Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int 25:422\u2013429","journal-title":"Kidney Int"},{"key":"2567_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000188535","volume":"70","author":"EJ Dorhout Mees","year":"1995","unstructured":"Dorhout Mees EJ, Koomans HA (1995) Understanding the nephrotic syndrome: what\u2019s new in a decade? Nephron 70:1\u201310","journal-title":"Nephron"},{"key":"2567_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1203\/00006450-197603000-00011","volume":"10","author":"A Gur","year":"1976","unstructured":"Gur A, Adefuin PY, Siegel NJ, Hayslett JP (1976) A study of the renal handling of water in lipoid nephrosis. Pediatr Res 10:197\u2013201","journal-title":"Pediatr Res"},{"key":"2567_CR12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1523-1755.1998.00864.x","volume":"53","author":"RW Schrier","year":"1998","unstructured":"Schrier RW, Fassett RG (1998) A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int 53:1111\u20131117","journal-title":"Kidney Int"},{"key":"2567_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000183206","volume":"37","author":"EA Brown","year":"1984","unstructured":"Brown EA, Markandu ND, Sagnella GA, Jones BE, MacGregor GA (1984) Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron 37:43\u201348","journal-title":"Nephron"},{"key":"2567_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000168052","volume":"10","author":"MD Shapiro","year":"1990","unstructured":"Shapiro MD, Hasbargen J, Hensen J, Schrier RW (1990) Role of aldosterone in the sodium retention of patients with nephrotic syndrome. Am J Nephrol 10:44\u201348","journal-title":"Am J Nephrol"},{"key":"2567_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000168800","volume":"15","author":"M Usberti","year":"1995","unstructured":"Usberti M, Gazzotti RM, Poiesi C, D\u2019Avanzo L, Ghielmi S (1995) Considerations on the sodium retention in nephrotic syndrome. Am J Nephrol 15:38\u201347","journal-title":"Am J Nephrol"},{"key":"2567_CR16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK (2009) Treatment of severe edema in children with nephrotic syndrome with diuretics alone\u2013a prospective study. Clin J Am Soc Nephrol 4:907\u2013913","journal-title":"Clin J Am Soc Nephrol"},{"key":"2567_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000188673","volume":"71","author":"B Jespersen","year":"1995","unstructured":"Jespersen B, Eiskjaer H, Mogensen CE, Sorensen SS, Pedersen EB (1995) Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Nephron 71:44\u201353","journal-title":"Nephron"},{"key":"2567_CR18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI115995","volume":"90","author":"JP Valentin","year":"1992","unstructured":"Valentin JP, Qiu C, Muldowney WP, Ying WZ, Gardner DG, Humphreys MH (1992) Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome. J Clin Invest 90:1302\u20131312","journal-title":"J Clin Invest"},{"key":"2567_CR19","first-page":"F3","volume":"271","author":"EY Lee","year":"1996","unstructured":"Lee EY, Humphreys MH (1996) Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention. Am J Physiol 271:F3\u2013F6","journal-title":"Am J Physiol"},{"key":"2567_CR20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.ki.5001860","volume":"70","author":"TR Kleyman","year":"2006","unstructured":"Kleyman TR, Myerburg MM, Hughey RP (2006) Regulation of ENaCs by proteases: an increasingly complex story. Kidney Int 70:1391\u20131392","journal-title":"Kidney Int"},{"key":"2567_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0070-2153(06)78002-4","volume":"78","author":"C Planes","year":"2007","unstructured":"Planes C, Caughey GH (2007) Regulation of the epithelial Na+ channel by peptidases. Curr Top Dev Biol 78:23\u201346","journal-title":"Curr Top Dev Biol"},{"key":"2567_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","volume":"20","author":"P Svenningsen","year":"2009","unstructured":"Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skott O (2009) Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 20:299\u2013310","journal-title":"J Am Soc Nephrol"},{"key":"2567_CR23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00467-013-2439-2","volume":"28","author":"RF Andersen","year":"2013","unstructured":"Andersen RF, Buhl KB, Jensen BL, Svenningsen P, Friis UG, Jespersen B, Rittig S (2013) Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC. Pediatr Nephrol 28:1227\u20131234","journal-title":"Pediatr Nephrol"},{"key":"2567_CR24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient. Kidney Int 82:840\u2013856","journal-title":"Kidney Int"},{"key":"2567_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"2567_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Hodson EM, Gipson DS (2013) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:409\u2013414","journal-title":"Pediatr Nephrol"},{"key":"2567_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"KDIGO Work Group","year":"2013","unstructured":"KDIGO Work Group (2013) KDIGO 2012 clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"2567_CR28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.62.5.811","volume":"62","author":"MA Engle","year":"1978","unstructured":"Engle MA, Lewy JE, Lewy PR, Metcoff J (1978) The use of furosemide in the treatment of edema in infants and children. Pediatrics 62:811\u2013818","journal-title":"Pediatrics"},{"key":"2567_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/00006450-198302000-00012","volume":"17","author":"J Prandota","year":"1983","unstructured":"Prandota J (1983) Pharmacokinetics of furosemide urinary elimination by nephrotic children. Pediatr Res 17:141\u2013147","journal-title":"Pediatr Res"},{"key":"2567_CR30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1681\/ASN.V1161100","volume":"11","author":"R Agarwal","year":"2000","unstructured":"Agarwal R, Gorski JC, Sundblad K, Brater DC (2000) Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. J Am Soc Nephrol 11:1100\u20131105","journal-title":"J Am Soc Nephrol"},{"key":"2567_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","volume":"2","author":"S Bansal","year":"2009","unstructured":"Bansal S, Lindenfeld J, Schrier RW (2009) Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2:370\u2013376","journal-title":"Circ Heart Fail"},{"key":"2567_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI113847","volume":"83","author":"DH Ellison","year":"1989","unstructured":"Ellison DH, Velazquez H, Wright FS (1989) Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 83:113\u2013126","journal-title":"J Clin Invest"},{"key":"2567_CR33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.V1271335","volume":"12","author":"JG Abdallah","year":"2001","unstructured":"Abdallah JG, Schrier RW, Edelstein C, Jennings SD, Wyse B, Ellison DH (2001) Loop diuretic infusion increases thiazide-sensitive Na(+)\/Cl(\u2212)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol 12:1335\u20131341","journal-title":"J Am Soc Nephrol"},{"key":"2567_CR34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","volume":"36","author":"NR Loon","year":"1989","unstructured":"Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36:682\u2013689","journal-title":"Kidney Int"},{"key":"2567_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cpt1977212234","volume":"21","author":"GR Lang","year":"1977","unstructured":"Lang GR, Westenfelder C, Nascimento L, Dhupelia VB, Arruda JA, Kane RE (1977) Metolazone and spironolactone in cirrhosis and the nephrotic syndrome. Clin Pharmacol Ther 21:234\u2013243","journal-title":"Clin Pharmacol Ther"},{"key":"2567_CR36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-1681.1975.tb01834.x","volume":"2","author":"GJ Schapel","year":"1975","unstructured":"Schapel GJ, Edwards DG, Robinson J (1975) Potassium-sparing effect of amiloride in a diuretic factorial study in man. Clin Exp Pharmacol Physiol 2:277\u2013287","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2567_CR37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.1.5906.481","volume":"1","author":"AM Davison","year":"1974","unstructured":"Davison AM, Lambie AT, Verth AH, Cash JD (1974) Salt-poor human albumin in management of nephrotic syndrome. Br Med J 1:481\u2013484","journal-title":"Br Med J"},{"key":"2567_CR38","first-page":"483","volume":"66","author":"R Gilles","year":"2008","unstructured":"Gilles R, den Heijer M, Ross AH, Sweep FC, Hermus AR, Wetzels JF (2008) Thyroid function in patients with proteinuria. Neth J Med 66:483\u2013485","journal-title":"Neth J Med"},{"key":"2567_CR39","first-page":"407","volume":"20","author":"S Afroz","year":"2011","unstructured":"Afroz S, Khan AH, Roy DK (2011) Thyroid function in children with nephrotic syndrome. Mymensingh Med J 20:407\u2013411","journal-title":"Mymensingh Med J"},{"key":"2567_CR40","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/ndt\/gfr665","volume":"27","author":"A Dagan","year":"2012","unstructured":"Dagan A, Cleper R, Krause I, Blumenthal D, Davidovits M (2012) Hypothyroidism in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 27:2171\u20132175","journal-title":"Nephrol Dial Transplant"},{"key":"2567_CR41","author":"K Kapoor","year":"2013","unstructured":"Kapoor K, Saha A, Dubey NK, Goyal P, Suresh CP, Batra V, Upadhayay AD (2013) Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome. Clin Exp Nephrol. doi: 10.1007\/s10157-013-0800-1","journal-title":"Clin Exp Nephrol"},{"key":"2567_CR42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ajcp\/65.1.73","volume":"65","author":"DE Hancock","year":"1976","unstructured":"Hancock DE, Onstad JW, Wolf PL (1976) Transferrin loss into the urine with hypochromic, microcytic anemia. Am J Clin Pathol 65:73\u201378","journal-title":"Am J Clin Pathol"},{"key":"2567_CR43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0272-6386(01)80122-0","volume":"37","author":"S Feinstein","year":"2001","unstructured":"Feinstein S, Becker-Cohen R, Algur N, Raveh D, Shalev H, Shvil Y, Frishberg Y (2001) Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function. Am J Kidney Dis 37:736\u2013742","journal-title":"Am J Kidney Dis"},{"key":"2567_CR44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(77)92498-9","volume":"2","author":"JM Barragry","year":"1977","unstructured":"Barragry JM, France MW, Carter ND, Auton JA, Beer M, Boucher BJ, Cohen RD (1977) Vitamin-D metabolism in nephrotic syndrome. Lancet 2:629\u2013632","journal-title":"Lancet"},{"key":"2567_CR45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1172\/JCI109327","volume":"63","author":"HH Malluche","year":"1979","unstructured":"Malluche HH, Goldstein DA, Massry SG (1979) Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome. J Clin Invest 63:494\u2013500","journal-title":"J Clin Invest"},{"key":"2567_CR46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","volume":"117","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J (2008) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117:224\u2013230","journal-title":"Circulation"},{"key":"2567_CR47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","volume":"118","author":"R Singhal","year":"2006","unstructured":"Singhal R, Brimble KS (2006) Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 118:397\u2013407","journal-title":"Thromb Res"},{"issue":"105\u201310","key":"2567_CR48","first-page":"110","volume":"155","author":"BA Kerlin","year":"2009","unstructured":"Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE (2009) Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 155(105\u201310):110","journal-title":"J Pediatr"},{"key":"2567_CR49","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","volume":"18","author":"RJ Glassock","year":"2007","unstructured":"Glassock RJ (2007) Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 18:2221\u20132225","journal-title":"J Am Soc Nephrol"},{"key":"2567_CR50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1345\/aph.1R530","volume":"47","author":"KJ Pincus","year":"2013","unstructured":"Pincus KJ, Hynicka LM (2013) Prophylaxis of thromboembolic events in patients with nephrotic syndrome. Ann Pharmacother 47:725\u2013734","journal-title":"Ann Pharmacother"},{"key":"2567_CR51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(12)80899-7","volume":"24","author":"M Ogi","year":"1994","unstructured":"Ogi M, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Takaeda M, Wada T, Naito T, Ikeda K, Goshima S (1994) Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis 24:427\u2013436","journal-title":"Am J Kidney Dis"},{"key":"2567_CR52","unstructured":"Committee on Infectious Diseases AAP (2012) Report of the committee on infectious diseases. In: Pickering LK (ed) Online electronic medical library, 29th edn. American Academy of Pediatrics, Elk Grove Village"},{"key":"2567_CR53","doi-asserted-by":"crossref","unstructured":"Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2011) Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 29(40):6834\u20136837","DOI":"10.1016\/j.vaccine.2011.07.053"},{"key":"2567_CR54","doi-asserted-by":"crossref","unstructured":"Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A (2008) High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol 23(7):1107\u20131113","DOI":"10.1007\/s00467-008-0782-5"},{"key":"2567_CR55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM199008303230905","volume":"323","author":"J Joven","year":"1990","unstructured":"Joven J, Villabona C, Vilella E, Masana L, Alberti R, Valles M (1990) Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323:579\u2013584","journal-title":"N Engl J Med"},{"key":"2567_CR56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-119-4-199308150-00002","volume":"119","author":"C Wanner","year":"1993","unstructured":"Wanner C, Rader D, Bartens W, Kramer J, Brewer HB, Schollmeyer P, Wieland H (1993) Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119:263\u2013269","journal-title":"Ann Intern Med"},{"key":"2567_CR57","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","volume":"44","author":"JD Ordonez","year":"1993","unstructured":"Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH (1993) The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 44:638\u2013642","journal-title":"Kidney Int"},{"key":"2567_CR58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00467-001-0793-y","volume":"17","author":"JM Silva","year":"2002","unstructured":"Silva JM, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro AL, Simal CJ, Ribeiro MC (2002) Premature acute myocardial infarction in a child with nephrotic syndrome. Pediatr Nephrol 17:169\u2013172","journal-title":"Pediatr Nephrol"},{"key":"2567_CR59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/BF00866337","volume":"8","author":"L Hopp","year":"1994","unstructured":"Hopp L, Gilboa N, Kurland G, Weichler N, Orchard TJ (1994) Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature. Pediatr Nephrol 8:290\u2013294","journal-title":"Pediatr Nephrol"},{"key":"2567_CR60","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00467-004-1460-x","volume":"19","author":"BL Lechner","year":"2004","unstructured":"Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ (2004) The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 19:744\u2013748","journal-title":"Pediatr Nephrol"},{"key":"2567_CR61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00467-008-1029-1","volume":"24","author":"MH Kniazewska","year":"2009","unstructured":"Kniazewska MH, Obuchowicz AK, Wielkoszynski T, Zmudzinska-Kitczak J, Urban K, Marek M, Witanowska J, Sieron-Stoltny K (2009) Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol 24:549\u2013554","journal-title":"Pediatr Nephrol"},{"key":"2567_CR62","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1529-0131(200006)43:6<1405::AID-ANR26>3.0.CO;2-V","volume":"43","author":"F Falaschi","year":"2000","unstructured":"Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, Perani G, Martini A (2000) Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 43:1405\u20131409","journal-title":"Arthritis Rheum"},{"key":"2567_CR63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000168648","volume":"13","author":"FN Hutchison","year":"1993","unstructured":"Hutchison FN (1993) Hormonal modulation of proteinuria in the nephrotic syndrome. Am J Nephrol 13:337\u2013346","journal-title":"Am J Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2567-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2567-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:37:16Z","timestamp":1646447836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2567-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["2567"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2567-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}